WCLC Updates in Locally Advanced NSCLC
Key opinion leaders provide insights on chemotherapy and radiotherapy in patients with unresectable, locally advanced non–small cell lung cancer (NSCLC).
EP: 1.WCLC Updates in KRAS and Rare EGFR-Mutated NSCLC
EP: 2.WCLC Updates on the Emergence of ADCs in NSCLC
EP: 3.WCLC Updates in Immunotherapy for NSCLC
EP: 4.WCLC Updates in Neoadjuvant Therapy for NSCLC
Now Viewing
EP: 5.WCLC Updates in Locally Advanced NSCLC
EP: 6.WCLC Updates in Small Cell Lung Cancer
Data from the following clinical trial are discussed:
- OA02.03 - Pembrolizumab Plus Platinum Chemotherapy and Radiotherapy in Unresectable, Locally Advanced Stage III NSCLC: KEYNOTE-799
Related Videos
Related Content
